Wednesday, February 2, 2011

Roche sees U.S. and European reforms weighing in 2011 (Reuters)

Reuters - Swiss drugmaker Roche struck a cautious note on 2011, as the sector grapples with U.S. healthcare reforms and a push in Europe for lower drug prices, after growth of its top-seller Avastin slowed sharply in 2010.

Amy Smart Angelina Jolie Angie Harmon Anna Faris Anna Friel

No comments:

Post a Comment